Literature DB >> 4215021

Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma.

A L Metzger, F R Singer, R Bluestone, C M Pearson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4215021     DOI: 10.1056/NEJM197412122912408

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 3.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

4.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401

5.  Focal mineralization defect during disodium etidronate treatment of calcinosis.

Authors:  R S Weinstein
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

6.  Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis.

Authors:  Takayuki Wakabayashi; Noriko Sasaki; Naofumi Chinen; Yasuo Suzuki
Journal:  Case Rep Rheumatol       Date:  2015-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.